Dermatology Residence Program, Centro Universitário FMABC, Santo André, SP, Brazil.
Dermatology Course, Centro Universitário FMABC, Santo André, SP, Brazil.
An Bras Dermatol. 2021 Mar-Apr;96(2):200-209. doi: 10.1016/j.abd.2020.08.010. Epub 2021 Jan 30.
The technological advancement of the pharmaceutical industry, resulting from the techniques of molecular biology and expansion of the knowledge of immunopathogenesis, has modified the therapeutic arsenal used in dermatology. Scientific research and regulatory standards cause drug costs to rise, thus making their use impossible in most public policies. In order to make high-cost drugs viable in the public health network, the Specialized Pharmaceutical Assistance Component was created. However, despite the frequent incorporation of medications, the constant requirement of drugs through lawsuits leads to exorbitant costs to the state budget. The present work analyzed through a descriptive observational study, the current situation of the Specialized Component and the involvement of medicines used in dermatology, through legal reviews, financial analyses, and medical articles, aiming at future incorporations for the specialty. When assessing the legal demands for dermatological drugs in the state of São Paulo, the specialty still has a low participation and psoriasis is the main disease involved in requiring drugs through the judicial system in the state. New methods of access to raw materials must be created to reduce legal issues. Cost-effectiveness and public planning studies are mandatory for incorporating new dermatological therapies.
制药行业的技术进步，源于分子生物学技术的发展和免疫发病机制知识的扩展，改变了皮肤科使用的治疗方法。科研和监管标准导致药品成本上升，因此在大多数公共政策中无法使用这些药品。为了使高价药品在公共卫生网络中可行，专门的药物援助部分应运而生。然而，尽管经常加入新的药物，但通过诉讼不断需要药物会导致国家预算的巨额支出。本工作通过描述性观察研究，分析了专门部分的现状和皮肤科使用的药物的参与情况，通过法律审查、财务分析和医学文章，旨在为该专业的未来加入提供参考。在评估圣保罗州皮肤科药物的法律需求时，该专业的参与度仍然较低，银屑病是该州通过司法系统要求药物的主要疾病。必须创造新的原材料获取方法来减少法律问题。成本效益和公共规划研究对于纳入新的皮肤科治疗方法是强制性的。
